Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class ITerminatedD-0631-2022

Drug recall · February 23, 2022

365 SKINNY High Intensity Capsules recall

Why: Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared sibutramine, a previously approved drug that was withdrawn from the US market due to safety concerns.

Class I: a reasonable chance the product could cause serious harm or death.

The recall

Product

365 SKINNY High Intensity Capsules, 600 mg, 30-count bottle, BODY BALANCE INTERNACIONAL

Lots / codes

Lot 102-26, Exp Dec 2022

Quantity
783 bottles
Company
Je Dois Lavoir LLC, Visalia, CA
Distribution
Sold online via website nationwide in the USA and Canada.
Initiated
August 2, 2021 · Voluntary: Firm initiated
Classified
February 23, 2022
Reported
February 23, 2022
Ended
May 2, 2023
How notified
Press Release

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.